The latest gastro-intestinal cancer news
Pairing imaging, AI may improve colon cancer screening, diagnosis
A research team from the lab of Quing Zhu, the Edwin H. Murty Professor of…
Browsing: GI Cancers
Colorectal cancer tumours both helped and hindered by T cells
Colorectal tumours are swarming with white blood cells, but whether these cells help or hinder…
Study finds treating precancerous growths in people with HIV reduces anal cancer by more than half
A team of researchers, including LSU Health New Orleans Infectious Diseases and Microbiology (USA) Professor…
p53 in liver cancer: The ultimate betrayal?
p53 is one of the most important proteins in cancer biology. Often referred to as…
Contrasting rates of survival for GI cancers in the Northern Territory
Survival rates for gastrointestinal (GI) cancer among Northern Territorians have improved in the past 30…
ESMO: New phase III data show tislelizumab significantly extended median overall survival by more than 6 months in first-line advanced oesophageal cancer in combination with chemotherapy
New results from the phase III RATIONALE 306 trial show that tislelizumab plus chemotherapy significantly improved…
New genomic technique identifies roots of upper GI cancers
Rampant inflammation has long been linked to cancer but exactly how it pushes healthy cells…
Causes of liver cancer are changing worldwide
The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol…
Aspirin may help slow down colorectal cancer evolution
Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help…
Treating precancerous anal lesions reduces anal cancer risk by more than half in people with HIV
A large clinical trial among people living with HIV has found that treating anal precancerous…